BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2021
View Archived Issues
Seletalisib shows trend towards clinical improvement in patients with primary Sjogren's syndrome
Read More
FN-EDA transgenic mice developed as a new model of glaucoma
Read More
Akouos develops VEGF gene therapy for the treatment of vestibular schwannoma
Read More
Platelet complement and innate immune system proteins elevated in age-related macular degeneration
Read More
AEterna Zentaris and University of Queensland initiate development of macimorelin for ALS
Read More
THCVHS shows superior IOP-lowering activity compared to glaucoma standard of care in vivo
Read More
Delaying the second dose of Pfizer vaccine from 3 to 12 weeks boosts immune response
Read More
FDA approves IND for phase II study of ketamine in patients with LID-PD
Read More
BeiGene discloses Bcl-2 inhibitors
Read More
BroadenBio presents FGFR4 inhibitors
Read More
Chromosomal fusion - an ALTernative tumor target for PARP inhibitors?
Read More
Interim phase I data for scAAV-2.5-IL1R as local gene therapy in OA of the knee
Read More
Rodin Therapeutics identifies new HDAC inhibitors
Read More
Accent Therapeutics presents METTL3 inhibitors
Read More
Ono Pharmaceutical and The Vanderbilt University divulge potassium channel modulators
Read More
Promising effect of oral TRPC6 inhibitor BI-749327 on pulmonary hypertension
Read More
Data presented from low-dose cohort of first-in-human trial FX-201
Read More
Unity opens enrollment in phase IIa study of UBX-1325 in DME
Read More
Antibody-cytokine chimera shows promise in vivo for melanoma
Read More
Camostat mesylate does not lead to significant improvement in patients hospitalized with COVID-19
Read More
New phase Ib/IIa study evaluates VB-119 in membranous nephropathy
Read More
Further data reported from MATINS study of bexmarilimab in solid tumors
Read More
BerGenBio reports phase II topline data on bemcentinib in hospitalized COVID-19 patients
Read More
Celltrion's CT-P59 demonstrates neutralizing capability against SARS-CoV-2 variants
Read More
Promising interim phase II data released on Medicago's adjuvanted COVID-19 vaccine candidate
Read More
PYC reports efficacy data from ADOA program in patient cell models
Read More